Project Grant R35GM154682
- The National Science Foundation Division of Chemistry awarded $525,000 to The Trustees of the University of Pennsylvania through the Mathematical and Physical Sciences federal grant program (CFDA 47.049) to support synthetic studies on herquline and lycopodium alkaloids from August 1, 2022 to July 31, 2025. Under this Project Grant, Professor Dirk Trauner of the University of Pennsylvania will develop new organoboron chemistry methods to synthesize the natural product herquline A, which has...
- The National Science Foundation awarded a $500,000 Project Grant to the California Institute of Technology under the Mathematical and Physical Sciences federal grant program (CFDA 47.049) to support the development of new transition metal-catalyzed reaction methods for synthesizing alkaloids with anticancer properties. Professor Brian Stoltz and his team at Caltech will utilize palladium-catalyzed reactions to rapidly construct the complex molecular frameworks of targeted marine-derived chemical...
- The National Institute of General Medical Sciences (NIGMS), through the Biomedical Research and Research Training program (CFDA 93.859), awarded a $259,966 project grant to Colorado State University to develop new synthetic strategies for functionalizing pyridine and diazine heterocycles. The goal is to introduce new methods to directly and selectively install a range of substituents onto these heterocyclic compounds, which are common motifs in FDA-approved drugs. The project, awarded on April...
- This Project Grant award from the National Science Foundation (NSF), under the Mathematical and Physical Sciences program (CFDA 47.049), supports research led by Professor Scott E. Denmark at the University of Illinois at Urbana-Champaign. The $800,000 award will fund a 4-year project to develop new catalytic methods for the stereoselective synthesis of pharmaceutically-relevant heterocyclic compounds. The research aims to use selenium-based catalysts to efficiently construct important ring...
- This Project Grant from the National Science Foundation Division of Chemistry, under the Mathematical and Physical Sciences program (CFDA 47.049), provides $221,000 to Professor Karl Scheidt of Northwestern University to develop new catalytic transformations for accessing saturated heterocycles through August 1, 2022 to July 31, 2023. The funding supports research aiming to facilitate access to chiral heterocyclic compounds through new bond-forming reactions, enabling the efficient and...
- Grant Award Summary The California Institute of Technology (Caltech) received a $149,264 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective January 20, 2026, with a completion date of September 24, 2028. This award supports the development of a concise dearomative approach to synthesize quinolizidine natural products, which are complex nitrogen-containing ring structures found in...
- This Project Grant award of $149,264, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research into diastereodivergent piperidine synthesis via hydrogen-bond donor (HBD) catalysis. The research addresses a critical bottleneck in drug development by proposing a novel catalytic strategy to enable general, diastereoselective synthesis of highly substituted piperidine derivatives—compounds that...
- Federal Project Grant Summary Professor Filippo Romiti at the University of Texas at Dallas is developing innovative chemical synthesis methods and strategies for the preparation of biologically active heterodimeric bisindole alkaloids under a CAREER grant awarded by the National Science Foundation's Division of Chemistry (Mathematical and Physical Sciences, CFDA 47.049). The research focuses on creating powerful and selective chemical transformations that enable the direct merger of monomeric...
- The National Science Foundation Division of Chemistry awarded a $1,050,000 Project Grant to the Scripps Research Institute under the Mathematical and Physical Sciences federal grant program (CFDA 47.049) to support research exploring attached-ring cross-coupling chemistry and its applications. Over a three-year period from August 1, 2022 to July 31, 2025, Professor Ryan Shenvi of Scripps Research Institute will develop new non-precious metal reagents and methods for concise syntheses of...
- This $650,000 Project Grant awarded by the National Science Foundation's (NSF) Mathematical and Physical Sciences program (CFDA 47.049) funds an industrial-academic collaboration between Princeton University and the Merck Catalysis Laboratory. The goal is to develop new sustainable catalytic methods for the large-scale synthesis of pharmaceutical drugs using earth-abundant metals like iron, cobalt, and nickel instead of rare precious metals. The research aims to identify viable catalytic...
NEW METHODS AND STRATEGIES FOR THE SCALABLE SYNTHESIS OF COMPLEX BIOACTIVE MOLECULES - ABSTRACT TO ENABLE RELIABLE ACCESS TO MEANINGFUL QUANTITIES OF BIOACTIVE NATURAL AND UNNATURAL COMPOUNDS WITH HIGHER COMPLEXITY, IT IS VITAL TO DEVISE NEW SYNTHESIS LOGICS AND DEVELOP NEW CHEMICAL TRANSFORMATIONS. IN THIS CONTEXT, WE PROPOSE TO INVESTIGATE THE HIGHLY COVETED IS THE RAPID ASSEMBLY OF POLYCYCLIC FRAMEWORKS ADORNED WITH SEVERAL CHIRAL CENTERS. OUR EXPLORATIONS FOCUS ON THE SYNTHESIS AND STUDY OF COMPLEX NATURAL PRODUCTS AND THEIR FULLY SYNTHETIC ANALOGUES WITH POTENTIALS FOR THE TREATMENT OF CANCER, NEUROLOGICAL DISORDERS, AND INFECTIOUS DISEASES. THE TERPENES AND ALKALOIDS WE IDENTIFIED AS TARGETS ARE PROMISING LEAD COMPOUNDS FOR THE DEVELOPMENT OF NEW MEDICINES, BUT THEIR UNKNOWN OR UNCLEAR MECHANISM OF ACTIONS AND THE LACK OF A DEPENDABLE WAY TO ACCESS THEM HAS SEVERELY HINDERED THEIR THERAPEUTICAL DEVELOPMENT. WE AIM TO SOLVE THIS ISSUE WHILE ALSO EXPANDING AND INNOVATING THE TOOLBOX AVAILABLE TO MEDICINAL AND SYNTHETIC CHEMISTS. IN FACT, THESE MOLECULES ARE NOT ONLY IMPORTANT FROM A BIOLOGICAL STANDPOINT, BUT THEY ALSO REPRESENT STATE-OF-THE-ART CHALLENGES FOR COMPLEX MOLECULE SYNTHESIS. THUS, THESE TOTAL SYNTHESIS EFFORTS STIMULATE THE INVENTION OF NEW CHEMICALS METHODS AND SERVE AS A PROVING GROUND FOR OUR NEW LOGICS AND EXISTING TRANSFORMATIONS TO SOLVE CRITICAL SYNTHESIS PROBLEMS IN COMPLEX SETTINGS. THE EXPECTED OUTCOME OF THE PROPOSED RESEARCH IS A) THE DEVELOPMENT OF NEW CATALYTIC STEREOSELECTIVE METHODS THAT GENERATE DENSELY SUBSTITUTED POLYCYCLIC BUILDING BLOCKS FOR SYNTHESIS, B) THE DESIGN OF NEW SYNTHESIS LOGICS THAT WILL FACILITATE THE PREPARATION OF COMPLEX FUNCTIONAL MOLECULES FOR WHICH THERE ARE CURRENTLY NO EFFICIENT SYNTHESIS ROADMAPS, C) RELIABLE ACCESS TO THE CHOSEN TARGET MOLECULES ENABLING THEIR USE AS BIOLOGICAL PROBES OR AS LEAD COMPOUNDS FOR DRUG DISCOVERY, D) A COLLECTION OF MEDICINALLY RELEVANT SYNTHETIC ANALOGUES FOR IN-DEPTH BIOLOGICAL EVALUATIONS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $390.0k | 5/7/25 | ||
| Not listed | $390.0k | 7/23/24 | ||
| Not listed | $390.0k | 7/23/24 |